Purdue Pharma

Purdue Pharma Says It Will Transform Into 'Public Benefit Company,' As It Files For Bankruptcy — Proposes $7.4 Billion Settlement In Opioid Case
Purdue Pharma, Sackler Family To Pay $7.4 Billion In Settlement Over OxyContin That Fueled 'Devastating' Opioid Epidemic
Massachusetts Attorney General Says Sacklers 'Will Be Held Responsible' After Supreme Court Vacates Purdue Bankruptcy Plan
Purdue Pharma, Sackler Family To Pay $7.4 Billion In Settlement Over OxyContin That Fueled 'Devastating' Opioid Epidemic
Massachusetts Attorney General Says Sacklers 'Will Be Held Responsible' After Supreme Court Vacates Purdue Bankruptcy Plan
Publicis To Pay $350M In First-Ever Opioid Marketing Settlement
Opioid Crisis: Billions At Stake As Supreme Court Grapples With Immunity For Sackler Family In Exchange For Settlement

Purdue Pharma Recent News

Sackler Family's $6B Commitment in Spotlight: Supreme Court Suspends Purdue Pharma's Settlement Over Opioid Lawsuits
The Supreme Court temporarily suspended a multi-billion-dollar bankruptcy agreement involving Purdue Pharma. This arrangement would insulate the company's Sackler family owners from civil lawsuits linked to the opioid epidemic.
|
Supreme Court Halts Purdue Pharma's $6B Settlement: Sackler Family's Shield From Opioid Lawsuits Challenged
On Thursday, the Supreme Court temporarily blocked a $6-billion bankruptcy settlement by Purdue Pharma, the maker of the opioid OxyContin, that would shield the Sackler family from civil lawsuits related to the opioid crisis. The court also announced that it will hear a challenge to the settlement by a U.S.
|
Sackler Family Can Keep Most Of Its Billions And Immunity, Rules Fed Appeals Court In Bankruptcy Deal
A federal appeals court in New York cleared the way for a bankruptcy deal for opioid manufacturer Purdue Pharma in a deal that will essentially protect the Sackler family from future lawsuits in exchange for a contribution of up to $6 billion. The Sacklers earned billions of dollars from the sale of the highly addictive OxyContin and other opio
|
Netflix Is Taking On The Opioid Crisis And Billionaire Sackler Family In New Series 'Painkiller'
A fictionalized retelling of events, Netflix (NASDAQ: NFLX) upcoming series "Painkiller" is a scripted limited series that explores some of the origins and aftermath of the opioid crisis in the United States which, as of November 2021, has resulted in 
|
Hulu's 'Dopesick' Creator Danny Strong Says Sackler Family's Purdue Pharma Created Devastating Opioid Crisis
The popular, if disturbing Hulu drama series, "Dopesick" starring Michael Keaton, Kaitlyn Dever, Rosario Dawson and Peter Sarsgaard tells the story of the devastating opioid crisis in the U.S.
|
Purdue Pharma Wins Bankruptcy Case, Sackler Family Wins Immunity From Opioid Lawsuits
After two years of contentious bargaining, a U.S. bankruptcy court judge approved a controversial plan that will dissolve Purdue Pharma, the company that has been blamed for fueling the nation's deadly opioid crisis.
|
'Further Gains Ahead': Stock Market Update For The Week Ahead
The Past Week, In A Nutshell What Happened: Last week ended negative alongside mixed messaging on stimulus.
|
Four Pharmas Settle Opioid Lawsuits Ahead Of Trial With Ohio Counties; 2,300 Cases Remain
|
Collegium Rallies On 'Value-Based Contract' With Cigna; Here's What It Means
|

Connect With Us

instagramlinkedinyoutube

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell

© 2025 Benzinga | All Rights Reserved